Real-time enrollment status for this waldenstrom's macroglobulinemia clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 12:47 AM UTC
| NCT Number | NCT04840602 |
| Recruiting Status | Recruiting |
| Condition | Waldenstrom's Macroglobulinemia |
| Phase | PHASE2 |
| Target Enrollment | 92 participants |
| Active Locations | 145 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | October 14, 2026 (2 days ago) |
As of October 16, 2026: Clinical trial NCT04840602 is currently recruiting participants. This phase2 study for waldenstrom's macroglobulinemia is actively seeking new participants at 145 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04840602 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 145 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04840602 was last updated 2 days ago (October 14, 2026). HelloStudys verifies this status automatically.